Treatment with isoliquiritigenin inhibits tumor growth, EMT, and metastasis in nude mice by decreasing miR-200c, miR-374a, c-Jun expression and increasing PTEN expression, thus preventing TNBC [112,113]. The gene discussed is PTEN; the disease is neoplasm.